健康元
(600380)
| 流通市值：224.00亿 | | | 总市值：224.00亿 |
| 流通股本：18.67亿 | | | 总股本：18.67亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 4,339,814,452.16 | 16,646,350,349.72 | 12,651,257,386.44 | 8,719,741,599.23 |
| 营业收入 | 4,339,814,452.16 | 16,646,350,349.72 | 12,651,257,386.44 | 8,719,741,599.23 |
| 二、营业总成本 | 3,296,136,273.86 | 13,123,515,536.16 | 9,992,088,727.85 | 6,852,636,758.88 |
| 营业成本 | 1,588,615,523.54 | 6,298,465,671.11 | 4,836,588,741.76 | 3,273,420,227.03 |
| 税金及附加 | 46,715,949.27 | 203,209,120.85 | 150,278,107.37 | 102,706,433.95 |
| 销售费用 | 1,097,660,861.66 | 4,434,442,281.05 | 3,428,038,993.64 | 2,399,063,230.2 |
| 管理费用 | 259,688,090.97 | 930,481,615.7 | 680,009,158.86 | 434,867,895.32 |
| 研发费用 | 377,100,491.98 | 1,661,757,980.9 | 1,211,596,866.4 | 765,166,559.76 |
| 财务费用 | -73,644,643.56 | -404,841,133.45 | -314,423,140.18 | -122,587,587.38 |
| 其中:利息费用 | 33,732,578.57 | 146,728,005.05 | 106,424,878.84 | 70,061,146.58 |
| 其中:利息收入 | 102,748,969.84 | 532,253,758.86 | 373,189,603.11 | 135,947,800.19 |
| 加:公允价值变动收益 | 1,161,062.53 | -25,419,715.12 | -46,003,628.22 | -39,314,888.38 |
| 加:投资收益 | 20,421,061.35 | 79,474,572.01 | 58,569,845.8 | 56,854,039.45 |
| 资产处置收益 | 306,572.18 | -169,901.01 | -200,478.63 | -342,359.46 |
| 资产减值损失(新) | -4,077,243.26 | -312,369,926.37 | -108,440,945.45 | -30,171,594.37 |
| 信用减值损失(新) | -6,583,395.98 | -16,846,468.56 | -17,737,505.85 | -22,209,391.69 |
| 其他收益 | 35,611,817.69 | 259,061,799 | 150,725,832.49 | 125,925,260.26 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 1,090,518,052.81 | 3,506,565,173.51 | 2,696,081,778.73 | 1,957,845,906.16 |
| 加:营业外收入 | 1,879,698.62 | 7,980,415.72 | 6,302,873.99 | 1,757,450.18 |
| 减:营业外支出 | 5,878,094.77 | 48,990,788.1 | 23,765,998.31 | 7,370,028.41 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 1,086,519,656.66 | 3,465,554,801.13 | 2,678,618,654.41 | 1,952,233,327.93 |
| 减:所得税费用 | 161,422,518.85 | 614,535,757.76 | 433,823,342.57 | 324,663,062.1 |
| 六、净利润 | 925,097,137.81 | 2,851,019,043.37 | 2,244,795,311.84 | 1,627,570,265.83 |
| 持续经营净利润 | 925,097,137.81 | 2,851,019,043.37 | 2,244,795,311.84 | 1,627,570,265.83 |
| 归属于母公司股东的净利润 | 439,798,106.55 | 1,442,779,722.23 | 1,083,649,154.75 | 815,434,734.9 |
| 少数股东损益 | 485,299,031.26 | 1,408,239,321.14 | 1,161,146,157.09 | 812,135,530.93 |
| (一)基本每股收益 | 0.24 | 0.76 | 0.57 | 0.43 |
| (二)稀释每股收益 | 0.24 | 0.76 | 0.57 | 0.43 |
| 八、其他综合收益 | -22,546,561.73 | -35,859,587.07 | -22,658,520.87 | 30,080,133.76 |
| 归属于母公司股东的其他综合收益 | -10,032,811.3 | -14,877,862.38 | 1,005,760.4 | 31,181,824.98 |
| 九、综合收益总额 | 902,550,576.08 | 2,815,159,456.3 | 2,222,136,790.97 | 1,657,650,399.59 |
| 归属于母公司股东的综合收益总额 | 429,765,295.25 | 1,427,901,859.85 | 1,084,654,915.15 | 846,616,559.88 |
| 归属于少数股东的综合收益总额 | 472,785,280.83 | 1,387,257,596.45 | 1,137,481,875.82 | 811,033,839.7 |
| 公告日期 | 2024-04-26 | 2024-04-03 | 2023-10-26 | 2023-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |